Department of Physiology and Anatomy University of North Texas Health Science Center Fort Worth TX.
Texas College of Osteopathic Medicine University of North Texas Health Science Center Fort Worth TX.
J Am Heart Assoc. 2022 Jan 18;11(2):e021726. doi: 10.1161/JAHA.121.021726. Epub 2022 Jan 11.
Background Circulating cell-free mitochondrial DNA (ccf-mtDNA) is a damage-associated molecular pattern that reflects cell stress responses and tissue damage, but little is known about ccf-mtDNA in preeclampsia. The main objectives of this study were to determine (1) absolute concentrations of ccf-mtDNA in plasma and mitochondrial DNA content in peripheral blood mononuclear cells and (2) forms of ccf-mtDNA transport in blood from women with preeclampsia and healthy controls. In addition, we sought to establish the association between aberrance in circulating DNA-related metrics, including ccf-mtDNA and DNA clearance mechanisms, and the clinical diagnosis of preeclampsia using bootstrapped penalized logistic regression. Methods and Results Absolute concentrations of ccf-mtDNA were reduced in plasma from women with preeclampsia compared with healthy controls (≤0.02), while mtDNA copy number in peripheral blood mononuclear cells did not differ between groups (>0.05). While the pattern of reduced ccf-mtDNA in patients with preeclampsia remained, DNA isolation from plasma using membrane lysis buffer resulted in 1000-fold higher ccf-mtDNA concentrations in the preeclampsia group (=0.0014) and 430-fold higher ccf-mtDNA concentrations in the control group (<0.0001). Plasma from women with preeclampsia did not induce greater Toll-like receptor-9-induced nuclear factor kappa-light-chain enhancer of activated B cells-dependent responses in human embryonic kidney 293 cells overexpressing the human gene (>0.05). Penalized regression analysis showed that women with preeclampsia were more likely to have lower concentrations of ccf-mtDNA as well as higher concentrations of nuclear DNA and DNase I compared with their matched controls. Conclusions Women with preeclampsia have aberrant circulating DNA dynamics, including reduced ccf-mtDNA concentrations and DNA clearance mechanisms, compared with gestational age-matched healthy pregnant women.
循环细胞游离线粒体 DNA(ccf-mtDNA)是一种损伤相关分子模式,反映细胞应激反应和组织损伤,但关于 preeclampsia 中的 ccf-mtDNA 知之甚少。本研究的主要目的是确定(1)血浆中 ccf-mtDNA 的绝对浓度和外周血单个核细胞中线粒体 DNA 含量,以及(2)来自 preeclampsia 妇女和健康对照者的血液中 ccf-mtDNA 的运输形式。此外,我们试图使用 bootstrap 惩罚逻辑回归来确定循环 DNA 相关指标(包括 ccf-mtDNA 和 DNA 清除机制)的异常与 preeclampsia 的临床诊断之间的关联。
与健康对照组相比,preclampsia 妇女血浆中的 ccf-mtDNA 绝对浓度降低(≤0.02),而外周血单个核细胞中的 mtDNA 拷贝数在两组之间没有差异(>0.05)。尽管 preeclampsia 患者的 ccf-mtDNA 减少模式仍然存在,但使用膜裂解缓冲液从血浆中分离 DNA 导致 preeclampsia 组的 ccf-mtDNA 浓度增加 1000 倍(=0.0014),对照组的 ccf-mtDNA 浓度增加 430 倍(<0.0001)。来自 preeclampsia 妇女的血浆不会诱导过表达人基因的人胚肾 293 细胞中 Toll 样受体-9 诱导的核因子 kappa-轻链增强子的激活 B 细胞依赖性反应增加(>0.05)。惩罚回归分析表明,与匹配的对照组相比,preclampsia 妇女更有可能具有较低的 ccf-mtDNA 浓度以及较高的核 DNA 和 DNA 酶 I 浓度。
与胎龄匹配的健康孕妇相比,preclampsia 妇女具有异常的循环 DNA 动力学,包括 ccf-mtDNA 浓度降低和 DNA 清除机制。